• 4754 Citations
  • 38 h-Index
1980 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Review article
Review article

Advanced strategies for treatment of Parkinson's disease: the role of early treatment.

Jann, M. W., 1 Jan 2011, In : The American journal of managed care. 17 Suppl 12

Research output: Contribution to journalReview article

7 Scopus citations

Alternative drug therapies for mania: A literature review

Jann, M. W., Garrelts, J. C., Ereshefsky, L. & Saklad, S. R., 1 Jan 1984, In : Drug Intelligence and Clinical Pharmacy. 18, 7-8, p. 577-589 13 p.

Research output: Contribution to journalReview article

4 Scopus citations

Antidepressant agents for the treatment of chronic pain and depression

Jann, M. W. & Slade, J. H., 1 Nov 2007, In : Pharmacotherapy. 27, 11, p. 1571-1587 17 p.

Research output: Contribution to journalReview article

124 Scopus citations

Buspirone: An Update on a Unique Anxiolytic Agent

Jann, M. W., 1 Jan 1988, In : Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 8, 2, p. 100-116 17 p.

Research output: Contribution to journalReview article

59 Scopus citations

Cholinesterase inhibitors for the treatment of Alzheimer's disease in the elderly

VanDenBerg, C. M., Kazmi, Y. & Jann, M. W., 1 Jan 2000, In : Drugs and Aging. 16, 2, p. 123-138 16 p.

Research output: Contribution to journalReview article

29 Scopus citations

Clinically significant drug interactions with atypical antipsychotics

Kennedy, W. K., Jann, M. W. & Kutscher, E. C., 1 Dec 2013, In : CNS Drugs. 27, 12, p. 1021-1048 28 p.

Research output: Contribution to journalReview article

46 Scopus citations

Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors

Jann, M. W., Shirley, K. L. & Small, G. W., 1 Jan 2002, In : Clinical Pharmacokinetics. 41, 10, p. 719-739 21 p.

Research output: Contribution to journalReview article

258 Scopus citations

Clinical Pharmacokinetics of the Depot Antipsychotics

Jann, M. W., Ereshefsky, L. & Saklad, S. R., 1 Jan 1985, In : Clinical Pharmacokinetics. 10, 4, p. 315-333 19 p.

Research output: Contribution to journalReview article

77 Scopus citations
33 Scopus citations

Drug interactions with antipsychotic agents incidence and therapeutic implications

ZumBrunnen, T. L. & Jann, M. W., 2 Jun 1998, In : CNS Drugs. 9, 5, p. 381-401 21 p.

Research output: Contribution to journalReview article

21 Scopus citations

Drug withdrawal syndromes. A literature review

Hodding, G. C., Jann, M. W. & Ackerman, I. P., 1 Dec 1980, In : Western Journal of Medicine. 133, 5, p. 383-391 9 p.

Research output: Contribution to journalReview article

26 Scopus citations

Emergency Treatment of Psychotic Symptoms: Pharmacokinetic Considerations for Antipsychotic Drugs

Milton, G. V. & Jann, M. W., 1 Jan 1995, In : Clinical Pharmacokinetics. 28, 6, p. 494-504 11 p.

Research output: Contribution to journalReview article

24 Scopus citations

Future of depot neuroleptic therapy: Pharmacokinetic and pharmacodynamic approaches

Ereshefsky, L., Saklad, S. R., Jann, M. W., Davis, C. M., Richards, A. & Seidel, D. R., 2 Aug 1984, In : Journal of Clinical Psychiatry. 45, 5 II, p. 50-59 10 p.

Research output: Contribution to journalReview article

62 Scopus citations

Implications for atypical antipsychotics in the treatment of schizophrenia: Neurocognition effects and a neuroprotective hypothesis

Jann, M. W., 1 Dec 2004, In : Pharmacotherapy. 24, 12 I, p. 1759-1783 25 p.

Research output: Contribution to journalReview article

38 Scopus citations

Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents

Jann, M. W. & Penzak, S. R., 1 Mar 2018, In : CNS Drugs. 32, 3, p. 241-257 17 p.

Research output: Contribution to journalReview article

12 Scopus citations

Major depression in women: a review of the literature.

Desai, H. D. & Jann, M. W., 1 Jan 2000, In : Journal of the American Pharmaceutical Association (Washington,D.C. : 1996). 40, 4, p. 525-537 13 p.

Research output: Contribution to journalReview article

68 Scopus citations

Movement disorders and new azapirone anxiolytic drugs

Jann, M. W., Froemming, J. H. & Borison, R. L., 1 Jan 1990, In : Journal of the American Board of Family Practice. 3, 2, p. 111-119 9 p.

Research output: Contribution to journalReview article

6 Scopus citations

Paroxetine, sertraline, and fluvoxamine: New selective serotonin reuptake inhibitors

Grimsley, S. R. & Jann, M. W., 1 Jan 1992, In : Clinical Pharmacy. 11, 11, p. 930-957 28 p.

Research output: Contribution to journalReview article

193 Scopus citations

Pharmacokinetics and Pharmacodynamics of Clozapine

Jann, M. W., Griley, S. R., Gray, E. C. & Chang, W. H., 1 Jan 1993, In : Clinical Pharmacokinetics. 24, 2, p. 161-176 16 p.

Research output: Contribution to journalReview article

203 Scopus citations

Pharmacokinetics of Haloperidol

Froemming, J. S., Lam, Y. W. F., Jann, M. W. & Davis, C. M., Dec 1989, In : Clinical Pharmacokinetics. 17, 6, p. 396-423 28 p.

Research output: Contribution to journalReview article

109 Scopus citations

Preclinical pharmacology of metrifonate

Jann, M. W., 1 Mar 1998, In : Pharmacotherapy. 18, 2 II SUPPL.

Research output: Contribution to journalReview article

33 Scopus citations

Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease

Jann, M. W., 1 Jan 2000, In : Pharmacotherapy. 20, 1 I, p. 1-12 12 p.

Research output: Contribution to journalReview article

155 Scopus citations

Selective serotonin reuptake inhibitor use and risk of gastrointestinal and intracranial bleeding

Yuet, W. C., Derasari, D., Sivoravong, J., Mason, D. & Jann, M., Feb 2019, In : Journal of the American Osteopathic Association. 119, 2, p. 102-111 10 p.

Research output: Contribution to journalReview article

3 Scopus citations

Smoking in patients receiving psychotrophic medications: A pharmacokinetic perspective

Desai, H. D., Seabolt, J. & Jann, M. W., 1 Jan 2001, In : CNS Drugs. 15, 6, p. 469-494 26 p.

Research output: Contribution to journalReview article

174 Scopus citations

The Evolving Role of Pharmacists in Transgender Health Care

Redfern, J. S. & Jann, M. W., 11 Apr 2019, In : Transgender Health. 4, 1, p. 118-130 13 p.

Research output: Contribution to journalReview article

Open Access

Therapeutic frontiers in Alzheimer's disease

Miller, S. W., Mahoney, J. M. & Jann, M. W., 30 Jun 1992, In : Pharmacotherapy. 12, 3, p. 217-231 15 p.

Research output: Contribution to journalReview article

11 Scopus citations

Treatment of panic and phobic disorders

Jann, M. W. & Kurtz, N. M., 1 Dec 1987, In : Clinical Pharmacy. 6, 12, p. 947-962 16 p.

Research output: Contribution to journalReview article

11 Scopus citations

Venlafaxine and nefazodone, two pharmacologically distinct antidepressants

Augustin, B. G., Cold, J. A. & Jann, M. W., 1 May 1997, In : Pharmacotherapy. 17, 3, p. 511-530 20 p.

Research output: Contribution to journalReview article

23 Scopus citations